Objective To investigate the clinical efficacy of gastrointestinal pacing combined with Bifidobacterium tetravaccine tablets in the treatment of functional dyspepsia (FD) and its effects on gastric motility and serum gastrointestinal function-related parameters. Methods A total of 108 patients with FD admitted to Jingjiang Hospital of Traditional Chinese Medicine from March 2022 to March 2024 were selected as study subjects and randomly divided into a control group (n=54) and an observation group (n=54) using the sealed envelope lottery method. The control group was treated with Bifidobacterium tetravaccine tablets, while the observation group received additional gastrointestinal pacing therapy on the basis of the control group. Both groups were treated continuously for 4 weeks. The clinical efficacy, time to symptom relief, serum gastrointestinal function-related parameters, gastric motility parameters, and total incidence of adverse reactions were compared between the two groups. Results The total effective rate in the observation group was 96.30% (52/54), which was higher than that in the control group (79.63% [43/54]) (P<0.05). The time to relief of abdominal pain, abdominal distension, decreased appetite, acid reflux, and belching in the observation group was shorter than that in the control group (all P<0.05). After 4 weeks of treatment, the serum levels of growth hormone, acetylcholinesterase, and motilin in both groups were increased compared with those before treatment, while the serum cholecystokinin level was decreased compared with that before treatment; moreover, the above parameters in the observation group were superior to those in the control group (all P<0.05). After 4 weeks of treatment, the antral contraction frequency, contraction amplitude, and motility index in both groups were increased compared with those before treatment, and all the above parameters in the observation group were higher than those in the control group (all P<0.05). The total incidence of adverse reactions in the two groups was 11.11% (6/54) and 7.41% (4/54), respectively, with no statistically significant difference (P>0.05). Conclusion The addition of gastrointestinal pacing to Bifidobacterium tetravaccine tablets can improve the clinical efficacy in FD patients and ameliorate gastric motility and serum gastrointestinal function-related parameters. However, its long-term benefits and applicability in broader populations still require further verification by studies with larger samples and longer follow-up periods.